Literature DB >> 417399

Dyskinesias evoked in monkeys by weekly administration of haloperidol.

B Weiss, S Santelli.   

Abstract

In two cebus (Cebus albifrons) monkeys given weekly oral doses of 0.25 milligram of haloperidol per kilogram, movement disorders appeared 1 to 8 hours after drug administration following the tenth weekly dose. These disorders included oral movements, peculiar postures, writhing, and stretching. Such reactions faded in intensity after the next two doses. Increasing the dose to 0.5 milligram per kilogram has elicited the disorders reliably after each weekly dose for almost 2 years. Similar reactions also developed in a squirrel monkey (Saimiri sciurea) treated weekly with haloperidol and in a third cebus monkey previously maintained for a year on a regimen of 0.25 milligram of haloperidol per kilogram on 5 days per week. These findings suggest an experimental model for determining the etiology of drug-induced movement disorders. They also suggest an unrecognized clinical problem.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 417399     DOI: 10.1126/science.417399

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  11 in total

1.  Spontaneous orofacial movements in rodents induced by long-term neuroleptic administration: a second opinion.

Authors:  G Ellison
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.

Authors:  R E See; G Ellison
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Lack of tolerance to haloperidol-induced acute dyskinesias in rhesus monkeys.

Authors:  R D Porsolt
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.

Authors:  H Lublin; J Gerlach; L Peacock
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Treatment schedule as a determinant of the development of tolerance to haloperidol.

Authors:  R J Carey; J DeVeaugh-Geiss
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Progressive changes in the acute dyskinetic syndrome as a function of repeated elicitation in squirrel monkeys.

Authors:  R Neale; S Gerhardt; S Fallon; J M Liebman
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Acute dyskinesias in monkeys elicited by halopemide, mezilamine and the "antidyskinetic" drugs, oxiperomide and tiapride.

Authors:  R Neale; S Fallon; S Gerhardt; J M Liebman
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Fluphenazine-induced acute and tardive dyskinesias in monkeys.

Authors:  B Kovacic; E F Domino
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Long-term chlorpromazine in rhesus monkeys: production of dyskinesias and changes in social behavior.

Authors:  W T McKinney; E C Moran; G W Kraemer; A J Prange
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  Pharmacologic manipulations of brain catecholamines and the behavior of Callithrix jacchus (marmoset).

Authors:  F Campos; F Arruda
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.